208 related articles for article (PubMed ID: 36519759)
21. Chronic Rapamycin administration via drinking water mitigates the pathological phenotype in a Krabbe disease mouse model through autophagy activation.
Del Grosso A; Carpi S; De Sarlo M; Scaccini L; Colagiorgio L; Alabed HBR; Angella L; Pellegrino RM; Tonazzini I; Emiliani C; Cecchini M
Biomed Pharmacother; 2024 Apr; 173():116351. PubMed ID: 38422660
[TBL] [Abstract][Full Text] [Related]
22. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
[TBL] [Abstract][Full Text] [Related]
23. Murine model of genetic demyelinating disease: the twitcher mouse.
Suzuki K; Taniike M
Microsc Res Tech; 1995 Oct; 32(3):204-14. PubMed ID: 8527855
[TBL] [Abstract][Full Text] [Related]
24. Visual System Impairment in a Mouse Model of Krabbe Disease: The Twitcher Mouse.
Tonazzini I; Cerri C; Del Grosso A; Antonini S; Allegra M; Caleo M; Cecchini M
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33374753
[TBL] [Abstract][Full Text] [Related]
25. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor.
Matsuda J; Vanier MT; Saito Y; Suzuki K; Suzuki K
Hum Mol Genet; 2001 Nov; 10(23):2709-15. PubMed ID: 11726558
[TBL] [Abstract][Full Text] [Related]
26. Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy.
Snook ER; Fisher-Perkins JM; Sansing HA; Lee KM; Alvarez X; MacLean AG; Peterson KE; Lackner AA; Bunnell BA
Am J Pathol; 2014 Feb; 184(2):382-96. PubMed ID: 24316110
[TBL] [Abstract][Full Text] [Related]
27. The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors.
Cantuti Castelvetri L; Givogri MI; Hebert A; Smith B; Song Y; Kaminska A; Lopez-Rosas A; Morfini G; Pigino G; Sands M; Brady ST; Bongarzone ER
J Neurosci; 2013 Jun; 33(24):10048-56. PubMed ID: 23761900
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow transplantation increases efficacy of central nervous system-directed enzyme replacement therapy in the murine model of globoid cell leukodystrophy.
Qin EY; Hawkins-Salsbury JA; Jiang X; Reddy AS; Farber NB; Ory DS; Sands MS
Mol Genet Metab; 2012 Sep; 107(1-2):186-96. PubMed ID: 22704480
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of a Krabbe Disease Gene Therapy.
Hordeaux J; Jeffrey BA; Jian J; Choudhury GR; Michalson K; Mitchell TW; Buza EL; Chichester J; Dyer C; Bagel J; Vite CH; Bradbury AM; Wilson JM
Hum Gene Ther; 2022 May; 33(9-10):499-517. PubMed ID: 35333110
[TBL] [Abstract][Full Text] [Related]
30. Somatic cell genetic analysis of the galactocerebrosidase gene: lack of complementation in human Krabbe disease/twitcher mouse cell hybrids.
Skiba MC; Lyerla TA; Konola JT; Raghavan S
J Neurosci Res; 1990 Dec; 27(4):472-8. PubMed ID: 2079710
[TBL] [Abstract][Full Text] [Related]
31. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
Igisu H; Suzuki K
Science; 1984 May; 224(4650):753-5. PubMed ID: 6719111
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Microproteomics Based Characterization of the Central and Peripheral Nervous System of a Mouse Model of Krabbe Disease.
Pellegrini D; Del Grosso A; Angella L; Giordano N; Dilillo M; Tonazzini I; Caleo M; Cecchini M; McDonnell LA
Mol Cell Proteomics; 2019 Jun; 18(6):1227-1241. PubMed ID: 30926673
[TBL] [Abstract][Full Text] [Related]
33. Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease?
Papini N; Giallanza C; Brioschi L; Ranieri FR; Giussani P; Mauri L; Ciampa MG; Viani P; Tringali C
Int J Biochem Cell Biol; 2022 Apr; 145():106184. PubMed ID: 35217188
[TBL] [Abstract][Full Text] [Related]
34. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
[TBL] [Abstract][Full Text] [Related]
35. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease.
Giri S; Khan M; Nath N; Singh I; Singh AK
J Neurochem; 2008 Jun; 105(5):1820-33. PubMed ID: 18248608
[TBL] [Abstract][Full Text] [Related]
36. Impaired Autophagy in Krabbe Disease: The Role of BCL2 and Beclin-1 Phosphorylation.
Papini N; Todisco R; Giussani P; Dei Cas M; Paroni R; Giallanza C; Tringali C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983059
[TBL] [Abstract][Full Text] [Related]
37. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy.
Rafi MA; Zhi Rao H; Passini MA; Curtis M; Vanier MT; Zaka M; Luzi P; Wolfe JH; Wenger DA
Mol Ther; 2005 May; 11(5):734-44. PubMed ID: 15851012
[TBL] [Abstract][Full Text] [Related]
38. Characterization of adipose-derived stromal/stem cells from the Twitcher mouse model of Krabbe disease.
Zhang X; Semon JA; Zhang S; Strong AL; Scruggs BA; Gimble JM; Bunnell BA
BMC Cell Biol; 2013 Apr; 14():20. PubMed ID: 23590629
[TBL] [Abstract][Full Text] [Related]
39. Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe's disease.
D'Auria L; Reiter C; Ward E; Moyano AL; Marshall MS; Nguyen D; Scesa G; Hauck Z; van Breemen R; Givogri MI; Bongarzone ER
PLoS One; 2017; 12(5):e0178103. PubMed ID: 28531236
[TBL] [Abstract][Full Text] [Related]
40. Murine, canine and non-human primate models of Krabbe disease.
Wenger DA
Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
